Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Clinical trial NCT04430842 · COMPLETED
Trial details
- NCT number
- NCT04430842
- Sponsor
- Quadriga Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2022-09-21
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.